There were 58, 61, 18, and 4 cases of prospectively observed endometrial cancer included in the survival analyses in path_MLH1, path_MSH2, path_MSH6, and path_PMS2 heterozygotes, respectively. The gene discussed is PMS2; the disease is endometrial cancer.